Profile data is unavailable for this security.
About the company
Evolva Holding Ltd is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.
- Revenue in CHF (TTM)4.16m
- Net income in CHF-101.22m
- Incorporated1997
- Employees49.00
- LocationEvolva Holding LtdDuggingerstrasse 23REINACH 4153SwitzerlandCHE
- Phone+41 614852000
- Fax+41 614852001
- Websitehttps://www.evolva.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modus Therapeutics Holding AB | 0.00 | -1.25m | 5.00m | 2.00 | -- | 6.08 | -- | -- | -0.5898 | -0.5898 | 0.00 | 0.2738 | 0.00 | -- | -- | 0.00 | -165.57 | -141.06 | -- | -278.44 | -- | -- | -- | -- | -- | -18.39 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -14.54m | 5.11m | 23.00 | -- | 0.2899 | -- | -- | -5.21 | -5.21 | 0.00 | 6.32 | 0.00 | -- | -- | 0.00 | -51.97 | -28.80 | -57.15 | -31.12 | -- | -- | -- | -- | -- | -114.19 | 0.0137 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| IXICO PLC | 6.80m | -2.11m | 5.20m | 89.00 | -- | 0.4576 | -- | 0.7656 | -0.0386 | -0.0386 | 0.1241 | 0.2076 | 0.4725 | -- | 3.54 | 67,415.73 | -14.69 | 4.35 | -16.58 | 5.33 | 46.90 | 62.09 | -31.10 | 6.61 | -- | -- | 0.0312 | 0.00 | -22.89 | 4.32 | -214.15 | -- | 92.12 | -- |
| Abera Bioscience AB | 0.00 | -637.24k | 5.22m | 6.00 | -- | 7.10 | -- | -- | -0.5213 | -0.5213 | 0.00 | 0.5733 | 0.00 | -- | -- | 0.00 | -73.37 | -79.42 | -98.59 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
| PCI Biotech Holding ASA | 486.60k | -1.30m | 5.41m | 7.00 | -- | 2.09 | -- | 11.13 | -0.4287 | -0.4287 | 0.1607 | 0.8548 | 0.1334 | -- | 0.9365 | 857,000.00 | -35.59 | -36.44 | -40.42 | -40.14 | -- | -- | -266.74 | -1,055.43 | -- | -- | 0.0147 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Chosa Oncology AB | 418.00 | -716.70k | 6.40m | -- | -- | 3.54 | -- | 15,323.94 | -0.1745 | -0.1745 | 0.00009 | 0.3054 | 0.0002 | -- | 0.0009 | -- | -28.72 | -51.96 | -31.51 | -61.92 | -- | -- | -171,540.00 | -708.47 | -- | -28.22 | 0.00 | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| Evolva Holding Ltd | 4.16m | -101.22m | 6.58m | 49.00 | -- | 1.18 | -- | 1.58 | -14.04 | -14.04 | 0.7083 | 0.77 | 0.0685 | -- | 1.91 | -- | -166.87 | -37.51 | -190.97 | -41.07 | -23.54 | -- | -2,434.99 | -818.05 | -- | 0.4155 | 0.00 | -- | 517.55 | -14.19 | -22.13 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 151.33k | -3.00m | 6.75m | 12.00 | -- | 1.62 | -- | 44.61 | -0.2614 | -0.2614 | 0.0106 | 0.1436 | 0.0386 | -- | 2.43 | 139,307.70 | -76.46 | -20.19 | -86.74 | -20.97 | -97.96 | -- | -1,980.40 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Sprint Bioscience AB | 7.10m | 1.23m | 6.83m | 36.00 | 5.55 | 4.37 | 5.28 | 0.9609 | 0.2108 | 0.2108 | 1.22 | 0.2677 | 2.38 | -- | 13.18 | 3,036,214.00 | 41.28 | -71.22 | 128.58 | -113.71 | 76.51 | 62.75 | 17.31 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Dextech Medical AB | 0.00 | -393.32k | 7.26m | 1.00 | -- | 2.93 | -- | -- | -0.2546 | -0.2546 | 0.00 | 1.60 | 0.00 | -- | -- | -- | -14.35 | -23.30 | -14.73 | -23.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.52 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -2.17m | 7.55m | 1.00 | -- | 4.19 | -- | -- | -2.25 | -2.25 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -111.12 | -122.02 | -119.99 | -154.70 | -- | -- | -- | -28,466.75 | -- | -55.53 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Milestone Medical Inc | 6.29k | -2.99m | 7.73m | 4.00 | -- | -- | -- | 1,228.98 | -0.6122 | -0.6122 | 0.0013 | -4.92 | 0.0109 | 0.5918 | 0.1213 | -- | -517.54 | -340.87 | -- | -- | -3,337.03 | -166.46 | -47,612.84 | -5,029.09 | 0.0067 | -34.89 | -- | -- | -65.34 | 92.41 | -16.23 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | -545.49k | -1.52m | 7.94m | 5.00 | -- | 4.57 | -- | -- | -0.1594 | -0.4121 | -0.0605 | 0.1603 | -0.0864 | -- | -- | -1,305,600.00 | -24.10 | -37.28 | -44.74 | -51.56 | -- | -- | -- | -2,077.34 | -- | -0.439 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| GENOMED SA | 4.92m | 130.84k | 8.22m | 44.00 | 62.85 | 3.99 | 30.98 | 1.67 | 0.4455 | 0.4455 | 16.75 | 7.02 | 2.17 | 5.85 | 14.12 | 503,111.40 | 5.77 | 7.77 | 6.39 | 9.19 | 44.00 | 38.53 | 2.66 | 3.87 | 4.64 | 30,446.00 | 0.00 | -- | 9.88 | 3.88 | 174.07 | -8.94 | -32.19 | -- |
Data as of Sep 20 2024. Currency figures normalised to Evolva Holding Ltd's reporting currency: Swiss Franc CHF
1.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 29 Aug 2024 | 91.38k | 1.26% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Jul 2024 | 31.34k | 0.43% |
| Credit Suisse AGas of 31 Jul 2024 | 7.22k | 0.10% |
| BlackRock Asset Management Schweiz AGas of 05 Sep 2024 | 6.72k | 0.09% |
| Quorus Verm�gensverwaltung AGas of 31 Jul 2024 | 800.00 | 0.01% |
| BlackRock Advisors (UK) Ltd.as of 31 Jul 2023 | 720.00 | 0.01% |
| Carne Global Fund Managers (Schweiz) AGas of 31 Jul 2024 | 476.00 | 0.01% |
| Migros Bank AGas of 31 Dec 2022 | 380.00 | 0.01% |
| LLB Asset Management AGas of 30 Jun 2024 | 240.00 | 0.00% |
| Dux Inversores SGIIC SAas of 30 Jun 2024 | 89.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
